Title: 2025-2026 Regular Session HR 174 PN 1246 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN1246
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HR 174 PN 1246 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1246 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.174 Session of 2025 INTRODUCED BY STRUZZI, CONKLIN, FREEMAN, HOHENSTEIN, KHAN, McNEILL, NEILSON, REICHARD, VENKAT AND ZIMMERMAN, APRIL 3, 2025 REFERRED TO COMMITTEE ON HEALTH, APRIL 3, 2025 A RESOLUTIONRecognizing the month of July 2025 as "Juvenile Arthritis Awareness Month" in Pennsylvania.WHEREAS, Juvenile arthritis is an umbrella term that refers to pediatric rheumatic diseases that can develop in children 16 years of age or younger; andWHEREAS, Juvenile idiopathic arthritis (JIA) is an autoinflammatory disease of an unknown origin and the most common type of arthritis in children; andWHEREAS, An autoinflammatory disease causes the immune system to become overactive even when there is no infection or illness to fight or mistakenly attack healthy cells and tissues; andWHEREAS, There is no evidence as to what causes JIA and no evidence has been found that foods, toxins, allergies or lack of vitamins play a role in developing the disease; andWHEREAS, Current research indicates that there is a genetic predisposition to JIA; andWHEREAS, Researchers believe that a trigger, such as a virus, 1234567891011121314151617 can initiate JIA in a child who has the genetic tendency; andWHEREAS, Systemic JIA, oligoarticular JIA, polyarticular JIA, juvenile psoriatic arthritis, enthesitis-related JIA and undifferentiated arthritis are the six subtypes of JIA; andWHEREAS, Nearly 300,000 children in the United States have some form of arthritis; andWHEREAS, Typical symptoms of arthritis include limping, stiffness when awakening, reluctance to use an arm or leg, reduced activity level, persistent fever, joint swelling and difficulty with fine motor skills; andWHEREAS, Most children with arthritis can expect to live normal lives and some even have their arthritis go into remission; andWHEREAS, There is a small number of specialists who treat JIA, and the Children's Hospital of Philadelphia is a leader in the field; andWHEREAS, According to the American College of Rheumatology, the best care for a child who has JIA is provided by a pediatric rheumatology team that has extensive experience and can diagnose and manage their complex needs; andWHEREAS, A pediatric rheumatology team may consist of a pediatric rheumatologist, a physical therapist, an occupational therapist, a social worker and a nurse specialist who coordinate care with other health professionals and school and community officials; andWHEREAS, The overall treatment goal for a child who has JIA is to control the symptoms, prevent joint damage and maintain function; andWHEREAS, Medications, including steroids, disease-modifying drugs and biologics, along with physical and occupational 20250HR0174PN1246 - 2 - 123456789101112131415161718192021222324252627282930 therapy, are used to treat JIA; andWHEREAS, Parents and caregivers of children who have JIA should be familiar with 29 U.S.C. Ch. 16, which may provide for special accommodations at school; andWHEREAS, Children who have JIA may be eligible for assistance through services provided by State agencies; therefore be itRESOLVED, That the House of Representatives recognize the month of July 2025 as "Juvenile Arthritis Awareness Month" in Pennsylvania.20250HR0174PN1246 - 3 - 123456789


================================================================================

Raw Text:
2025-2026 Regular Session HR 174 PN 1246 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1246 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.174 Session of 2025 INTRODUCED BY STRUZZI, CONKLIN, FREEMAN, HOHENSTEIN, KHAN, McNEILL, NEILSON, REICHARD, VENKAT AND ZIMMERMAN, APRIL 3, 2025 REFERRED TO COMMITTEE ON HEALTH, APRIL 3, 2025 A RESOLUTIONRecognizing the month of July 2025 as "Juvenile Arthritis Awareness Month" in Pennsylvania.WHEREAS, Juvenile arthritis is an umbrella term that refers to pediatric rheumatic diseases that can develop in children 16 years of age or younger; andWHEREAS, Juvenile idiopathic arthritis (JIA) is an autoinflammatory disease of an unknown origin and the most common type of arthritis in children; andWHEREAS, An autoinflammatory disease causes the immune system to become overactive even when there is no infection or illness to fight or mistakenly attack healthy cells and tissues; andWHEREAS, There is no evidence as to what causes JIA and no evidence has been found that foods, toxins, allergies or lack of vitamins play a role in developing the disease; andWHEREAS, Current research indicates that there is a genetic predisposition to JIA; andWHEREAS, Researchers believe that a trigger, such as a virus, 1234567891011121314151617 can initiate JIA in a child who has the genetic tendency; andWHEREAS, Systemic JIA, oligoarticular JIA, polyarticular JIA, juvenile psoriatic arthritis, enthesitis-related JIA and undifferentiated arthritis are the six subtypes of JIA; andWHEREAS, Nearly 300,000 children in the United States have some form of arthritis; andWHEREAS, Typical symptoms of arthritis include limping, stiffness when awakening, reluctance to use an arm or leg, reduced activity level, persistent fever, joint swelling and difficulty with fine motor skills; andWHEREAS, Most children with arthritis can expect to live normal lives and some even have their arthritis go into remission; andWHEREAS, There is a small number of specialists who treat JIA, and the Children's Hospital of Philadelphia is a leader in the field; andWHEREAS, According to the American College of Rheumatology, the best care for a child who has JIA is provided by a pediatric rheumatology team that has extensive experience and can diagnose and manage their complex needs; andWHEREAS, A pediatric rheumatology team may consist of a pediatric rheumatologist, a physical therapist, an occupational therapist, a social worker and a nurse specialist who coordinate care with other health professionals and school and community officials; andWHEREAS, The overall treatment goal for a child who has JIA is to control the symptoms, prevent joint damage and maintain function; andWHEREAS, Medications, including steroids, disease-modifying drugs and biologics, along with physical and occupational 20250HR0174PN1246 - 2 - 123456789101112131415161718192021222324252627282930 therapy, are used to treat JIA; andWHEREAS, Parents and caregivers of children who have JIA should be familiar with 29 U.S.C. Ch. 16, which may provide for special accommodations at school; andWHEREAS, Children who have JIA may be eligible for assistance through services provided by State agencies; therefore be itRESOLVED, That the House of Representatives recognize the month of July 2025 as "Juvenile Arthritis Awareness Month" in Pennsylvania.20250HR0174PN1246 - 3 - 123456789